Biopsies of involved and uninvolved skin from psoriatic patients and of normal skin were stained immunocytochemically with monoclonal antibodies against urokinasetype (u-PA) and tissue-type (t-PA) plasminogen activator using a multilayer peroxidase technique. epidermis form psoriatic lesions showed focal staining for u-PA in and between the basal keratinocytes in the suprapapillary epidermal areas, while t-PA was found in the superficial keratinizing cells, including both stratum spinosum and the parakeratotic layer. No staining of keratinocytes was observed in uninvolved and normal skin. The specificity of the staining was supported by the finding that 3 different monoclonal antibodies and polyclonal antibodies against each of the plasmino...
Although increased levels of plasminogen activators have been found in psoriatic lesions, the role o...
To search for autoantigens in psoriatic plaques, we screened cDNA libraries of plaque epidermis with...
As a psoriatic lesion develops at sites of previously uninvolved skin, cytokines and their subsequen...
Biopsies of involved and uninvolved skin from psoriatic patients and of normal skin were stained imm...
Elevated levels of the serine proteinase plasminogen activator are observed in psoriatic lesions. In...
Elevated levels of the serine proteinase plasminogen activator are observed in psoriatic lesions. In...
To investigate the role of plasminogen activator (PA) in cutaneous disease, we have used biochemical...
Plasminogen activator (PA), which catalyzes the conversion of plasminogen to the proteinase plasmin,...
Plasminogen activator (PA), which catalyzes the conversion of plasminogen to the proteinase plasmin,...
Using immunohistochemistry and in situ hybridization, we have characterized the expression and local...
Urokinase- and tissue-type plasminogen activators (u-PA and t-PA) were identified immunohistochemica...
Abnormalities of the cutaneous plasminogen/plasminogen activator system have been associated with ac...
ψ-3 is a monoclonal antibody that recognizes a 135,000 molecular weight structural component of matu...
Background: Although increased levels of plasminogen activators have been found in psoriatic lesions...
BACKGROUND: Although increased levels of plasminogen activators have been found in psoriatic lesions...
Although increased levels of plasminogen activators have been found in psoriatic lesions, the role o...
To search for autoantigens in psoriatic plaques, we screened cDNA libraries of plaque epidermis with...
As a psoriatic lesion develops at sites of previously uninvolved skin, cytokines and their subsequen...
Biopsies of involved and uninvolved skin from psoriatic patients and of normal skin were stained imm...
Elevated levels of the serine proteinase plasminogen activator are observed in psoriatic lesions. In...
Elevated levels of the serine proteinase plasminogen activator are observed in psoriatic lesions. In...
To investigate the role of plasminogen activator (PA) in cutaneous disease, we have used biochemical...
Plasminogen activator (PA), which catalyzes the conversion of plasminogen to the proteinase plasmin,...
Plasminogen activator (PA), which catalyzes the conversion of plasminogen to the proteinase plasmin,...
Using immunohistochemistry and in situ hybridization, we have characterized the expression and local...
Urokinase- and tissue-type plasminogen activators (u-PA and t-PA) were identified immunohistochemica...
Abnormalities of the cutaneous plasminogen/plasminogen activator system have been associated with ac...
ψ-3 is a monoclonal antibody that recognizes a 135,000 molecular weight structural component of matu...
Background: Although increased levels of plasminogen activators have been found in psoriatic lesions...
BACKGROUND: Although increased levels of plasminogen activators have been found in psoriatic lesions...
Although increased levels of plasminogen activators have been found in psoriatic lesions, the role o...
To search for autoantigens in psoriatic plaques, we screened cDNA libraries of plaque epidermis with...
As a psoriatic lesion develops at sites of previously uninvolved skin, cytokines and their subsequen...